REG
Asset Logo

Regis Healthcare Limited

πŸ‡¦πŸ‡Ί ASX

πŸ“ˆ HIGH PRICE GROWTH

🩺 HEALTH CARE

Compare
Add to watchlist
πŸ‘‘ Overview

πŸ“ˆ Performance

πŸ’° Dividends

πŸ’΅ Cost

πŸƒ Esg

πŸ€“ Advanced

πŸ‘¨β€πŸ‘©β€πŸ‘§β€πŸ‘¦ Community

πŸ“ˆ

+ 26.05%
Annual Growth

5 years average annual growth

πŸ’°

2.51%
Annual dividend yield

Based on the most recent dividend

πŸ’΅

$ 500
Minimum Order

Due to regulatory requirements

🌏

4
Pearlers Invested

Since January 2020

πŸ‘‘ Overview

Key information
πŸ”Ž Fund Overview

Regis Healthcare Ltd. engages in the provision of residential aged care services. The company is headquartered in Melbourne, Victoria and currently employs 9,000 full-time employees. The company went IPO on 2014-10-07. The firm provides services through residential aged care homes, home care service hubs, day therapy and day respite centers and retirement villages. Its residential care provides services, including aging-in-place, short stays and respite care, specialist dementia care, and palliative care. The company owns and operates specialist retirement and independent living villages in Blackburn South, Norwood, and Queensland. Its short-term care services are tailored to individual needs and include things like personal care, help with tidying up, transport to appointments, and meal preparation. The company offers in-home respite care in a range of locations across Australia. The firm caters to approximately 7600 people across Australia. The firm also operates five residential aged care homes with 644 beds in South-East Queensland.

πŸ“ˆ Performance

Price History

+60.67%

1M

1Y

10Y

Graph

Table

Unsure how much or often to invest?
πŸ—“οΈ Investing frequency calculator

Determine the investment frequency needed to reach your goals

Try it out β†’
πŸ’΅ Investing amount calculator

Determine the recurring investment needed to reach your goals

Try it out β†’
⏱️ Investing duration calculator

Determine how long you will need to invest to reach your goals

Try it out β†’

πŸ’° Dividends

Payouts

πŸ’° Annual Dividend Yield*

2.51%

πŸ’° Annual Dividend Earnings Per $1,000 invested**

$25.09

πŸ’° Most Recent Dividend Franked Percentage Estimate

50.00%

πŸ’° Average Dividend Franked Percentage Estimate

73.01 %

πŸ’° Dividend reinvestment

Learn more

* Based on the most recent dividend

** Calculated by multiplying the most recent dividend yield by $1,000

Estimate your dividend

If you held

$

of REG, your last dividend payment(s) would have been:

$ 155.05

on Wed Sep 25 2024

$ 176.52

on Thu Apr 11 2024

*Disclaimer: The information provided in this calculator is only a model to show you how long you need to invest for to achieve your goal, based on several factors, including past performance which is not an indicator of future performance. It is not a prediction and relies on assumptions, such as interest rates, that may vary and change the actual outcome. The results shown are only estimates and are not intended to be relied on when making a financial decision. Consider whether to get advice from a licensed financial adviser before making any financial decision.

Dividend History

1Y

5Y

10Y

Graph

Table

Year
Yearly Dividend Earnings Per Share
Franking Estimate

2024

$0.13

50.00%

2023

$0.09

50.00%

2022

$0.06

50.00%

2021

$0.07

50.00%

2020

$0.04

Infinity%

2019

$0.15

50.00%

2018

$0.18

100.00%

2017

$0.20

100.00%

2016

$0.15

100.00%

2015

$0.18

100.00%

πŸ’΅ Costs

πŸ’΅

6.50 AUD*
Purchase Fee

*$5.50 with Pearler Prepay

πŸ’Ό

N/A
Management Fee

Included in unit price, not charged by Pearler

πŸ’Έ

Want to know the long term costs?
Calculate the historic long term costs to hold your investments
πŸ’Έ Net fee calculator

πŸƒ Environmental, Social and Governance scores ℹ️

🌳

Environmental Score
73

A measure of an organisations or investment's impact on the natural environment, including factors such as carbon emissions, resource usage, and pollution

πŸ•ŠοΈ

Social Score
71

An assessment of an organisations management practices, board structure, transparency, and accountability, reflecting its commitment to ethical behavior and responsible decision-making.

βš–οΈ

Governance Score
65

An evaluation of an organisations impact on society, focusing on factors such as employee welfare, diversity and inclusion, community engagement, and product safety and quality.

πŸ€“ Advanced information

Technical Info

πŸ’° Price*

$6.70

*Price may be up to 24 hours old

πŸ‘©β€πŸ‘©β€πŸ‘¦ Community Insights

How our community is investing

🌏 Pearlers invested in REG

4

πŸ“Š Total Capital Earnings

$14K

πŸ”ƒ Average investment frequency

10 weeks

πŸ’΅ Average investment amount

$3,402

⏰ Last time a customer invested in REG

21 days
REG investor breakdown
πŸ’΅ Income of investors

More than 200k

150k - 200k

100k - 150k

25%

50k - 100k

25%

Less than 50k

50%
πŸ‘Ά Age of investors

18 - 25

26 - 34

50%

35 - 90

50%
πŸ™‹ Legal gender of investors

Female

75%

Male

25%

Pearlers who invest in REG also invest in...

Telix Pharmaceuticals Limited

TLX

Telix Pharmaceuticals Ltd. engages in the development and commercialization of several clinical-stage oncology assets. The company is headquartered in Melbourne, Victoria. The company went IPO on 2017-11-15. The firm is focused on the development and commercialization of diagnostic and therapeutic radiopharmaceuticals and associated medical devices. The company is developing a portfolio of clinical and commercial stage products that aims to address significant unmet medical needs in oncology and rare diseases. Its core pipeline is focused on prostate cancer, renal cancer, brain cancer (glioma) and rare diseases (hematologic cancers and bone marrow conditioning). Its pipelines include TLX591, TLX592 (alpha-RADmAb), TLX591-CDx, TLX250, TLX250-CDx, TLX101, TLX101-CDx, TLX300, TLX300-CDx, TLX66, and TLX66-CDx. TLX591 is a radio antibody-drug conjugate (rADC) directed at prostate-specific membrane antigen (PSMA). Its product QUANTM Irradiation System (QIS), enables production of important medical isotopes such as gallium-68 (68Ga), zirconium-89 (89Zr), technetium-99m (99mTc) and copper-64 (64Cu).

πŸ™Œ Performance (5Yr p.a)

229.50%

πŸ“Š Share price

$22.58 AUD

🧬 BIOTECHNOLOGY

Find Out More

VAS.AX was created on 2009-05-04 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard Australian Shares Index ETF seeks to track the return of the S&P/ASX 300 Index before taking into account fees, expenses and tax.

πŸ™Œ Performance (5Yr p.a)

4.35%

πŸ“Š Share price

$104.33 AUD

🧱 MATERIALS

⛳️ DIVERSIFIED

πŸ’Έ FINANCIALS

IVV.AX was created on 2007-10-10 by iShares. The fund's investment portfolio concentrates primarily on large cap equity. The Fund aims to provide investors with the performance of an index, before fees and expenses. The index is designed to measure the performance of large capitalisation US equities.

πŸ™Œ Performance (5Yr p.a)

19.63%

πŸ“Š Share price

$61.01 AUD

πŸ“ˆ HIGH PRICE GROWTH

πŸ‡ΊπŸ‡Έ UNITED STATES

Estia Health Ltd. engages in the provision of residential aged care services. The company is headquartered in Sydney, New South Wales and currently employs 8,220 full-time employees. The company went IPO on 2014-12-05. The firm is engaged in the provision of services in residential aged care homes. The firm operates approximately 72 homes, including 25 homes in Victoria, 19 homes in South Australia, 18 homes in New South Wales and 10 homes in Queensland. These homes have approximately 6,596 operational places. The firm operates single rooms. The company cares for approximately 8,000 residents every year. The firm provides short-term respite care, long-term care, dementia care, palliative care and emergency care. Respite care offers a short-term option for people requiring care and for their care givers that may need a break. The firm operates its homes across various locations, such as Aberfoyle Park, Albany Creek, Albury, Altona Meadows, Ardeer, Bannockburn, Benalla, Dandenong, Epping, Wattle Glen, Lockleys, Flagstaff Hill, Knoxfield, Melton South, and others.

πŸ™Œ Performance (5Yr p.a)

7.50%

πŸ“Š Share price

$3.08 AUD

🩺 HEALTH CARE

DHHF is an all-in-one investment solution, constructed using a passive blend of cost-effective ETFs traded on the ASX and other global exchanges. The ETF has a 100% allocation to shares, and is invested in a blend of large, mid and small cap equities from Australia, global developed and emerging markets, offering investors exposure to an β€˜all-cap, all-world’ share portfolio with the potential for high growth over the long term. The ETF provides exposure to approximately 8,000 equity securities listed on over 60 global exchanges, in one ASX trade.

πŸ“Š Share price

$36.06 AUD

Want more shares? Try these...

Reece Ltd. engages in supplying plumbing, bathroom, heating, ventilation, air-conditioning, waterworks and refrigeration products to customers in the trade, retail and commercial markets. The company is headquartered in Melbourne, Victoria and currently employs 9,000 full-time employees. The firm operates through two geographical segments: Australia and New Zealand (ANZ) and United States of America (United States). Its plumbing and bathroom products are sourced both locally and internationally. Its bathroom and kitchen products include tapware and accessories, toilets, basins, showers, vanities and furniture, baths, and spas, sinks and troughs, bathroom, and kitchen appliances. Its plumbing products include piping and fittings, hot water systems, tools, valves, roofing, toilets, tapware, and wastes. Its civil products include pipe and fittings, valves, sewer and drainage, electrical pipe and fittings, fire, and water tanks. The company distributes products to commercial and residential customers through approximately 900 branches in Australia, New Zealand, and the United States.

πŸ™Œ Performance (5Yr p.a)

27.56%

πŸ“Š Share price

$24.38 AUD

πŸ“ˆ HIGH PRICE GROWTH

πŸ”¨ COMMERCIAL SERVICES & SUPPLIES

REIT.AX was created on 2019-03-29 by VanEck. The fund's investment portfolio concentrates primarily on real estate equity. REIT.AX seeks to provide investors with access to a diversified portfolio of international property securities

πŸ™Œ Performance (5Yr p.a)

-4.11%

πŸ“Š Share price

$16.50 AUD

🏠 REAL ESTATE

🌏 GLOBAL

RareX Ltd. is an exploration company. The company is headquartered in Subiaco, Western Australia. The company went IPO on 2007-07-11. The company is engaged in curating a portfolio of carbonatite related prospects within which the Khaleesi Project represents the exploration flagship. The exploration focus of the business is on the Khaleesi Project in the East Yilgarn which is a district-scale, elevated-niobium, and alkaline intrusive complex. The firm's engineering and commercial focus is on offtake and approvals at the mid-study-level, Cummins Range Project, a carbonatite hosted rare earth and phosphate project, containing magnet grade rare earths and battery grade phosphates and undeveloped rare earths project. The new Khaleesi Project is located along strike from Ponton Dyke, the Cundeelee carbonatite, and the Tropicana Gold mine. The Khaleesi Project is located adjacent to the Mulga Rocks deposits on the transition of the Yilgarn Craton to the Albany-Fraser Belt, specifically in the Northern Foreland Unit.

πŸ™Œ Performance (5Yr p.a)

-15.22%

πŸ“Š Share price

$0.01 AUD

⛏️ MINING

πŸ“Š Share price

$0.00 AUD
Compare
Add to watchlist